( OTC-BB:SNDC, OTC-BB:VOLN )

News from VolitionRX Limited A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

21 Apr, 2017, 08:26 ET Volition opens a new Research and Development facility in Belgium with a state of the art, purpose-built laboratory

VolitionRx Limited (NYSE MKT: VNRX) opened its new research and development facility this week. A video showcasing the new facility and...


28 Mar, 2017, 16:01 ET Volition America, Inc. Retains Strategic Expert in Securing Non-Dilutive Funding Opportunities in the United States

Volition America, Inc., a wholly-owned U.S. subsidiary of VolitionRx Limited (NYSE MKT: VNRX), today announced the engagement of Deborah Vollmer...


20 Mar, 2017, 06:30 ET VolitionRx Limited Announces the Formation of Volition America, Inc.

VolitionRx Limited (NYSE MKT: VNRX) today announced the creation of a wholly-owned U.S. subsidiary, Volition America, Inc., which will be based in...


14 Mar, 2017, 13:56 ET VolitionRx Limited Celebrates CE Mark Announcement By Ringing Closing Bell at the New York Stock Exchange

VolitionRx Limited (NYSE MKT: VNRX) celebrated the company's recent announcement of a CE mark for its Nu.QTM Colorectal Cancer Screening Triage...


13 Mar, 2017, 06:30 ET VolitionRx Limited to Ring the New York Stock Exchange Closing Bell on Monday, March 13th at 4 pm Eastern Daylight Time

VolitionRx Limited (NYSE MKT: VNRX) announced today that members of its senior management team and Board of Directors, including Chief Executive...


06 Feb, 2015, 08:00 ET VolitionRx Limited Prices Public Offering of Common Stock

VolitionRx Limited (NYSE MKT: VNRX), a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer types...


24 Nov, 2014, 08:00 ET VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014

VolitionRx Limited (OTCQB: VNRX), a life sciences company focused on developing diagnostic tests for cancer and other conditions, today announced...


05 Nov, 2014, 08:00 ET VolitionRx to Present at the SeeThruEquity Conference

VolitionRx Limited (OTCQB: VNRX), a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer types and...


31 Oct, 2014, 08:00 ET VolitionRx Initiates Sponsorship of Two-time Cancer Survivor to Drive Awareness for the Importance of Early Cancer Detection

VolitionRx Limited (OTCQB: VNRX), a life sciences company focused on developing blood-based diagnostic tests, today announced...


02 Oct, 2014, 08:00 ET VolitionRx Announces Prostate Cancer Collaboration with the University of Texas MD Anderson Cancer Center

VolitionRx Limited (OTCQB: VNRX), a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, today...


05 Sep, 2014, 06:30 ET VolitionRx to Present at the Aegis Capital Corp. 2014 Healthcare & Technology Conference

 VolitionRx Limited (OTCQB: VNRX), a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer...


02 Dec, 2013, 06:30 ET VolitionRx Finds Simple Blood Test Detects 85% of Colorectal Cancers and Over 50% of Polyps

 VolitionRx Limited (VNRX:OB), a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, today...


29 Nov, 2013, 08:30 ET VolitionRx to Present at the 6th Annual LD Micro Conference

 VolitionRx Limited (VNRX:OB), a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, today...


14 Nov, 2013, 06:30 ET VolitionRx Expands Sample Size to 11,000 in Pivotal Colorectal Cancer Trial with Hvidovre Hospital, Denmark

VolitionRx Limited (VNRX:OB), a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, today...


07 Nov, 2013, 06:30 ET First VolitionRx Study Data Presented at CNAPS, Baltimore

 VolitionRx Limited (OTC: VNRX), a life sciences company focused on developing blood-based diagnostic tests for different types of...


26 Sep, 2013, 06:30 ET VolitionRx and Active Motif enter into Distribution Agreement for Volition's Research Use Only ELISA Kits

 VolitionRx Limited (OTC: VNRX), a life sciences company focused on developing blood-based diagnostic tests for different types of...


03 Sep, 2013, 06:30 ET VolitionRx-led Consortium Awarded euro 780 000 ($1M approx.) Eurostars Grant

 VolitionRx Limited (OTC: VNRX), a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, is...


22 Jul, 2013, 06:30 ET VolitionRx to use Innova Biosciences' Biotin Technology in its Epigenetic Research Kits

VolitionRx Limited (OTC: VNRX), a life sciences company focused on the development of blood-based diagnostic tests, has signed a non-exclusive...


01 May, 2013, 06:30 ET Racepoint Group Appointed by VolitionRx to Raise Awareness of its new Early-Stage Cancer Diagnostic

VolitionRx Limited (OTC: VNRX), a life sciences company that is developing blood-based diagnostic tests for different types of cancer, has retained...


04 Apr, 2013, 06:30 ET VolitionRx Files Two Patent Applications

 VolitionRx Limited (OTC: VNRX), a life sciences company focused on developing blood-based diagnostic tests, announces that it has filed two...


26 Mar, 2013, 07:00 ET VolitionRx Hires Head of US Operations, Jason Terrell MD

VolitionRx Limited (OTC: VNRX), a life sciences company focused on developing blood-based diagnostic tests, announces that it has hired Jason...


09 Jan, 2013, 06:30 ET VolitionRx Announces Collaboration with Wales Cancer Bank

 VolitionRx Limited (OTC: VNRX), a life sciences company focused on developing blood-based diagnostic tests, announces that it will commence a...


17 Dec, 2012, 06:30 ET Volition Launches NuQ® Epigenetic Immunoassays for Research Use

 VolitionRx Limited (OTC: VNRX), a life sciences company focused on developing blood-based diagnostic tests, announces the launch of NuQ®,...


05 Nov, 2012, 06:30 ET VolitionRx's Preliminary Diagnostic Clinical Trial Results Show High Sensitivity and Specificity for Colon, Breast and Lung Cancers

 VolitionRx Limited (OTC: VNRX), a life sciences company focused on developing blood-based diagnostic tests, today announced preliminary...


21 Aug, 2012, 06:30 ET VolitionRX to Begin Prospective Clinical Trial in Colon Cancer

 VolitionRX Limited, a life sciences company focused on developing blood-based diagnostic tests, announces that its subsidiary Belgian Volition...